NMO‐IgG autoantibody is now considered a useful serum biomarker of neuromyelitis optica
(NMO). A series of clinical and pathological observations suggest that NMO‐IgG may play a …

NMO-IgG, the auto-antibody specific to the aquaporin-4 (AQP4) water channel associated
with the autoimmune inflammatory disease neuromyelitis optica (NMO), is considered to be …

Although the co-occurrence of myelitis and optic neuritis that characterizes neuromyelitis
optica (NMO) was recognized over a century ago, distinguishing NMO from multiple …

NMO‐IgG autoantibody selectively binds to aquaporin‐4 (AQP4), the most abundant water
channel in the central nervous system and is now considered a useful serum biomarker of …

Neuromyelitis optica (NMO) is a recurrent inflammatory disease that preferentially targets the
optic nerves and spinal cord. The presence of antibodies to the water channel protein …

Neuromyelitis optica (NMO) is an inflammatory disease that selectively affects the optic
nerves and spinal cord. The discovery of NMO-IgG targeting aquaporin-4 (AQP4) in NMO …

Background Neuromyelitis optica (NMO), a severe demyelinating disease, represents itself
with optic neuritis and longitudinally extensive transverse myelitis. Serum NMO-IgG …

Neuromyelitis optica (NMO)-immunoglobulin G (IgG) is a clinically validated serum
biomarker that distinguishes relapsing central nervous system (CNS) inflammatory …

Autoantibodies against astrocyte water channel aquaporin-4 (AQP4) are highly specific for
the neuroinflammatory disease neuromyelitis optica (NMO). We measured the binding of …

Antibodies to aquaporin-4 (also known as AQP4-Ab or NMO-IgG) are sensitive and highly
specific serum markers of autoimmune neuromyelitis optica (NMO). Second-generation …